BIOTON S.A. (WSE:BIO)

Poland flag Poland · Delayed Price · Currency is PLN
4.150
+0.050 (1.22%)
Jun 13, 2025, 5:00 PM CET
Market Cap 356.34M
Revenue (ttm) 235.90M
Net Income (ttm) -16.43M
Shares Out 85.86M
EPS (ttm) -0.19
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 20,578
Average Volume 44,703
Open 4.010
Previous Close 4.100
Day's Range 4.000 - 4.150
52-Week Range 2.800 - 4.250
Beta 0.34
RSI 56.57
Earnings Date Aug 28, 2025

About BIOTON

BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1989
Employees 364
Stock Exchange Warsaw Stock Exchange
Ticker Symbol BIO
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.